Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients.
Danion F, Sparsa L, Arnaud L, Alsaleh G, Lefebvre F, Gies V, Martin T, Lukas C, Durckel J, Ardizzone M, Javier RM, Kleinmann JF, Moreau P, Blaison G, Goetz J, Chatelus E, Gottenberg JE, Sibilia J, Sordet C.
Danion F, et al. Among authors: sparsa l.
RMD Open. 2017 Dec 29;3(2):e000555. doi: 10.1136/rmdopen-2017-000555. eCollection 2017.
RMD Open. 2017.
PMID: 29435362
Free PMC article.